Articles published by Benzinga
Pfizer Faces Court Over Depo-Provera Brain Tumor Claims
September 26, 2025
bioAffinity Stock Up Nearly 90%: What's Driving the Surge?
September 26, 2025
Expert Outlook: Palo Alto Networks Through The Eyes Of 27 Analysts
September 26, 2025
4 Analysts Assess Jabil: What You Need To Know
September 26, 2025
Decoding Applied Mat's Options Activity: What's the Big Picture?
September 26, 2025
Expert Outlook: Apple Through The Eyes Of 38 Analysts
September 26, 2025
12 Analysts Assess Apellis Pharmaceuticals: What You Need To Know
September 26, 2025
P/E Ratio Insights for Cadence Design Systems
September 26, 2025
How Do Investors Really Feel About Option Care Health Inc?
September 26, 2025
Looking Into Houlihan Lokey Inc's Recent Short Interest
September 26, 2025
Is the Market Bullish or Bearish on Modine Manufacturing Co?
September 26, 2025
Forecasting The Future: 10 Analyst Projections For DexCom
September 26, 2025
Costco Shares Are Trading Lower Friday: What's Going On?
September 26, 2025
What's Going On With PACCAR Shares Friday?
September 26, 2025
Hims & Hers Powers YieldMax's Latest Options-Based Income ETF
September 26, 2025
Sanofi Expands Insulin Savings Program To Cover All US Patients
September 26, 2025
Your AstraZeneca Medicine Could Be Cheaper As Much As 70%
September 26, 2025
Dogecoin Falls 17% In 1 Week: Can Whales Save The DOGE Bull Run?
September 26, 2025
Via Benzinga
These Analysts Cut Their Forecasts On CarMax After Downbeat Q2 Results
September 26, 2025
FDA Approves Crinetics Pharma's First Daily Pill For Rare Growth Disorder
September 26, 2025
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.